| Literature DB >> 17390370 |
Oliver McConnell1, Alvin Bach, Carl Balibar, Neal Byrne, Yanxuan Cai, Guy Carter, Michael Chlenov, Li Di, Kristi Fan, Igor Goljer, Yanan He, Don Herold, Michael Kagan, Edward Kerns, Frank Koehn, Christina Kraml, Vasilios Marathias, Brian Marquez, Leonard McDonald, Lisa Nogle, Christopher Petucci, Gerhard Schlingmann, Gregory Tawa, Mark Tischler, R Thomas Williamson, Alan Sutherland, William Watts, Mairead Young, Mei-Yi Zhang, Yingru Zhang, Dahui Zhou, Douglas Ho.
Abstract
The application of Chiral Technology, or the (extensive) use of techniques or tools for the determination of absolute stereochemistry and the enantiomeric or chiral separation of racemic small molecule potential lead compounds, has been critical to successfully discovering and developing chiral drugs in the pharmaceutical industry. This has been due to the rapid increase over the past 10-15 years in potential drug candidates containing one or more asymmetric centers. Based on the experiences of one pharmaceutical company, a summary of the establishment of a Chiral Technology toolbox, including the implementation of known tools as well as the design, development, and implementation of new Chiral Technology tools, is provided.Mesh:
Substances:
Year: 2007 PMID: 17390370 DOI: 10.1002/chir.20399
Source DB: PubMed Journal: Chirality ISSN: 0899-0042 Impact factor: 2.437